Trivitron Healthcare Appoints Rajesh Patel as CEO of In-Vitro Diagnostics Business
CEO Insights team, 0
Dr.GSK Velu, Chairman & Managing Director, Trivitron Healthcare, asserts, “In his new role, Rajesh will be at the helm of the company’s IVD business growth and expansion plans. His enthusiastic approach,progressive effort will provide a new leadership to IVD team and will help the division to reach a new milestone. We look forward to an exciting journey along with him and wish him all the success.”
I am excited by the opportunity to build on the great foundation and momentum achieved by the Trivitron Group and lead the company through the next stage of its strategic development
Commenting on his appointment, Rajesh says, “I am excited by the opportunity to build on the great foundation and momentum achieved by the Trivitron Group and lead the company through the next stage of its strategic development. I am committed to ensure that we not only stay at the forefront in this space but we continue to innovate and lead the market.”
Expressing on the appointment, Chandra Ganjoo, Executive Director, Group CPO & Head Corporate Communications, adds, “Rajesh’s strategic leadership, operational excellence expertise in healthcare and passion for innovation will be great assets to us as we grow in the coming years. Rajesh will be playing a significant role in reshaping the IVD business and the Trivitron group’s international footprint.”
Trivitron Healthcare was founded in 1997 by Velu and today it provides affordable healthcare solutions to the healthcare industry. Having a solid expertise in R&D, Trivitron manufactures and distributes exceptional medical technology products to 180 countries.